Effectiveness and Safety of Newer Antidiabetic Medications for Ramadan Fasting Diabetic Patients

Hypoglycemia is the most common side effects for most glucose-lowering therapies. It constitutes a serious risk that faces diabetic patients who fast during Ramadan (the 9th month in the Islamic calendar). New glucose-lowering classes like dipeptidyl peptidase-4 (DPP-4) inhibitors, glucagon-like pep...

Descripción completa

Detalles Bibliográficos
Autor principal: Mudher Mikhael, Ehab
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi Publishing Corporation 2016
Materias:
Review Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5013205/
https://www.ncbi.nlm.nih.gov/pubmed/27642611
http://dx.doi.org/10.1155/2016/6962574

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5013205/
https://www.ncbi.nlm.nih.gov/pubmed/27642611
http://dx.doi.org/10.1155/2016/6962574

Ejemplares similares